全文获取类型
收费全文 | 110643篇 |
免费 | 9520篇 |
国内免费 | 5594篇 |
专业分类
耳鼻咽喉 | 2526篇 |
儿科学 | 1224篇 |
妇产科学 | 2887篇 |
基础医学 | 6143篇 |
口腔科学 | 848篇 |
临床医学 | 12113篇 |
内科学 | 12018篇 |
皮肤病学 | 699篇 |
神经病学 | 2936篇 |
特种医学 | 5654篇 |
外国民族医学 | 53篇 |
外科学 | 19656篇 |
综合类 | 19569篇 |
现状与发展 | 3篇 |
一般理论 | 1篇 |
预防医学 | 4161篇 |
眼科学 | 477篇 |
药学 | 5580篇 |
29篇 | |
中国医学 | 607篇 |
肿瘤学 | 28573篇 |
出版年
2024年 | 197篇 |
2023年 | 1313篇 |
2022年 | 2854篇 |
2021年 | 3977篇 |
2020年 | 3785篇 |
2019年 | 3137篇 |
2018年 | 2993篇 |
2017年 | 3252篇 |
2016年 | 4042篇 |
2015年 | 3766篇 |
2014年 | 7451篇 |
2013年 | 6199篇 |
2012年 | 7524篇 |
2011年 | 8154篇 |
2010年 | 6822篇 |
2009年 | 6499篇 |
2008年 | 6322篇 |
2007年 | 6791篇 |
2006年 | 6287篇 |
2005年 | 5843篇 |
2004年 | 4543篇 |
2003年 | 3993篇 |
2002年 | 3328篇 |
2001年 | 3195篇 |
2000年 | 2634篇 |
1999年 | 2047篇 |
1998年 | 1729篇 |
1997年 | 1471篇 |
1996年 | 954篇 |
1995年 | 844篇 |
1994年 | 687篇 |
1993年 | 417篇 |
1992年 | 391篇 |
1991年 | 323篇 |
1990年 | 296篇 |
1989年 | 263篇 |
1988年 | 273篇 |
1987年 | 222篇 |
1986年 | 165篇 |
1985年 | 164篇 |
1984年 | 112篇 |
1983年 | 62篇 |
1982年 | 97篇 |
1981年 | 76篇 |
1980年 | 71篇 |
1979年 | 48篇 |
1978年 | 51篇 |
1977年 | 27篇 |
1976年 | 21篇 |
1975年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
《Archivos de bronconeumología》2022,58(3):246-254
We have updated recommendations on 12 controversial topics that were published in the 2013 National Consensus on the diagnosis, risk stratification and treatment of patients with pulmonary embolism (PE). A comprehensive review of the literature was performed for each topic, and each recommendation was evaluated in two teleconferences. For diagnosis, we recommend against using the Pulmonary Embolism Rule Out Criteria (PERC) rule as the only test to rule out PE, and we recommend using a D-dimer cutoff adjusted to age to rule out PE. We suggest using computed tomography pulmonary angiogram as the imaging test of choice for the majority of patients with suspected PE. We recommend using direct oral anticoagulants (over vitamin K antagonists) for the vast majority of patients with acute PE, and we suggest using anticoagulation for patients with isolated subsegmental PE. We recommend against inserting an inferior cava filter for the majority of patients with PE, and we recommend using full-dose systemic thrombolytic therapy for PE patients requiring reperfusion. The decision to stop anticoagulants at 3 months or to treat indefinitely mainly depends on the presence (or absence) and type of risk factor for venous thromboembolism, and we recommend against thrombophilia testing to decide duration of anticoagulation. Finally, we suggest against extensive screening for occult cancer in patients with PE. 相似文献
3.
4.
Qing-Yang Que Lin-Cheng Zhang Jia-Qi Bao Sun-Bin Ling Xiao Xu 《World journal of gastrointestinal surgery》2022,14(5):397-408
Over the last 40 years, the incidence and prevalence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) have continued to increase. Compared to other epithelial neoplasms in the same organ, GEP-NENs exhibit indolent biological behavior, resulting in more chances to undergo surgery. However, the role of surgery in high-grade or advanced GEP-NENs is still controversial. Surgery is associated with survival improvement of well-differentiated high-grade GEP-NENs, whereas poorly differentiated GEP-NENs that may benefit from resection require careful selection based on Ki67 and other tissue bio markers. Additionally, surgery also plays an important role in locally advanced and metastatic disease. For locally advanced GEP-NENs, isolated major vascular involvement is no longer an absolute contraindication. In the setting of metastatic GEP-NENs, radical intended surgery is recommended for patients with low-grade and resectable metastases. For unresectable metastatic disease, a variety of surgical approaches, including cytoreduction of liver metastasis, liver transplantation, and surgery after neoadjuvant treatment, show survival benefits. Primary tumor resection in GEP-NENs with unresectable metastatic disease is associated with symptom control, prolonged survival, and improved sensitivity toward systemic therapies. Although there is no established neoadjuvant or adjuvant strategy, increasing attention has been given to this emerging research area. Some studies have reported that neoadjuvant therapy effectively reduces tumor burden, improves the effectiveness of subsequent surgery, and decreases surgical complications. 相似文献
5.
6.
7.
《European journal of surgical oncology》2019,45(6):931-940
BackgroundIsolated local recurrent or persistent esophageal cancer (EC) after curative intended definitive (dCRT) or neoadjuvant chemoradiotherapy (nCRT) with initially omitted surgery, is a potential indication for salvage surgery. We aimed to evaluate safety and efficacy of salvage surgery in these patients.Material and methodsA systematic literature search following PRISMA guidelines was performed using databases of PubMed/Medline. All included studies were performed in patients with persistent or recurrent EC after initial treatment with dCRT or nCRT, between 2007 and 2017. Survival analysis was performed with an inverse-variance weighting method.ResultsOf the 278 identified studies, 28 were eligible, including a total of 1076 patients. Postoperative complications after salvage esophagectomy were significantly more common among patients with isolated persistent than in those with locoregional recurrent EC, including respiratory (36.6% versus 22.7%; difference in proportion 10.9 with 95% confidence interval (CI) [3.1; 18.7]) and cardiovascular complications (10.4% versus 4.5%; difference in proportion 5.9 with 95% CI [1.5; 10.2]). The pooled estimated 30- and 90-day mortality was 2.6% [1.6; 3.6] and 8.0% [6.3; 9.8], respectively. The pooled estimated 3-year and 5-year overall survival (OS) were 39.0% (95% CI: [35.8; 42.2]) and 19.4% [95% CI:16.5; 22.4], respectively. Patients with isolated persistent or recurrent EC after initial CRT had similar 5-year OS (14.0% versus 19.7%, difference in proportion −5.7, 95% CI [-13.7; 2.3]).ConclusionsSalvage surgery is a potentially curative procedure in patients with locally recurrent or persistent esophageal cancer and can be performed safely after definitive or neoadjuvant chemoradiotherapy when surgery was initially omitted. 相似文献
8.
9.
10.
目的 探讨食管癌高、低发区食管鳞癌患者的生存状况及其影响因素。方法 收集38 741例经病理学证实为食管鳞癌患者的资料,其中,高发区患者23 273例(60.1%),低发区15 468例(39.9%)。所有患者均行食管癌根治术。运用卡方检验分析不同临床病理特征患者的组间差异,Kaplan-Meier法绘制不同临床病理特征患者的生存曲线并用Log rank进行检验。多因素Cox比例风险回归模型法分析影响生存的主要因素。结果 低发区男性患者所占比例高于高发区(P<0.001),低发区诊断年龄≥50岁食管癌患者所占比例高于高发区(P<0.001)。高发区食管鳞癌患者的整体生存优于低发区患者(P<0.001)。Cox比例风险回归模型综合分析结果表明:高低发区、性别、确诊年龄、肿瘤部位、分化程度、TNM分期和肿瘤家族史均是影响食管鳞癌患者生存的独立因素。结论 高发区食管鳞癌患者整体生存优于低发区;低发区是食管鳞癌患者预后差的独立危险因素。 相似文献